Who are Clostridium butyricum capsule's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Clostridium butyricum capsules.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/clostridium-butyricum-capsule.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Clostridium butyricum capsule — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clostridium butyricum capsule (Clostridium butyricum capsule) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live biotherapeutic agent. Area: Gastroenterology.

marketed Live biotherapeutic agent Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Clostridium butyricum capsule (Clostridium butyricum capsule) — Xijing Hospital of Digestive Diseases. Clostridium butyricum is a live biotherapeutic that colonizes the gut and produces butyrate, a short-chain fatty acid that supports intestinal barrier function and modulates immune homeostasis.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Clostridium butyricum capsule TARGET	Clostridium butyricum capsule	Xijing Hospital of Digestive Diseases	marketed	Live biotherapeutic agent
Clostridium butyricum capsules	Clostridium butyricum capsules	The Affiliated Hospital of Qingdao University	marketed	Live biotherapeutic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live biotherapeutic agent class)

The Affiliated Hospital of Qingdao University · 1 drug in this class
Xijing Hospital of Digestive Diseases · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Clostridium butyricum capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/clostridium-butyricum-capsule. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab